Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,975 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH, Broderick JP, Chen X, Chen G, Sharma VK, Kim JS, Thang NH, Cao Y, Parsons MW, Levi C, Huang Y, Olavarría VV, Demchuk AM, Bath PM, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Ricci S, Roffe C, Pandian J, Billot L, Woodward M, Li Q, Wang X, Wang J, Chalmers J; ENCHANTED Investigators and Coordinators. Anderson CS, et al. Among authors: chalmers j. N Engl J Med. 2016 Jun 16;374(24):2313-23. doi: 10.1056/NEJMoa1515510. Epub 2016 May 10. N Engl J Med. 2016. PMID: 27161018 Free article. Clinical Trial.
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
Harrap SB, Tzourio C, Cambien F, Poirier O, Raoux S, Chalmers J, Chapman N, Colman S, Leguennec S, MacMahon S, Neal B, Ohkubo T, Woodward M; PROGRESS Collaborative Group. Harrap SB, et al. Among authors: chalmers j. Hypertension. 2003 Sep;42(3):297-303. doi: 10.1161/01.HYP.0000088322.85804.96. Epub 2003 Aug 18. Hypertension. 2003. PMID: 12925557
Clinical implications of PROGRESS: questions and answers.
Chalmers J, Adams HP Jr, Donnan GA, Fox K, MacMahon S, Mancia G, Tzourio C. Chalmers J, et al. J Hypertens Suppl. 2003 Jun;21(5):S21-4. doi: 10.1097/00004872-200306005-00005. J Hypertens Suppl. 2003. PMID: 12953852 No abstract available.
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Rodgers A, Chapman N, Woodward M, Liu LS, Colman S, Lee A, Chalmers J, MacMahon S; Perindopril Protection against Recurrent Stroke Study Collaborative Group. Rodgers A, et al. Among authors: chalmers j. J Hypertens. 2004 Mar;22(3):653-9. doi: 10.1097/00004872-200403000-00030. J Hypertens. 2004. PMID: 15076173 Clinical Trial.
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Hasegawa Y, Yamaguchi T, Omae T, Woodward M, Chalmers J; PROGRESS CT Substudy Investigators. Hasegawa Y, et al. Among authors: chalmers j. Hypertens Res. 2004 Mar;27(3):147-56. doi: 10.1291/hypres.27.147. Hypertens Res. 2004. PMID: 15080373 Free article. Clinical Trial.
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Arima H, Hart RG, Colman S, Chalmers J, Anderson C, Rodgers A, Woodward M, MacMahon S, Neal B; PROGRESS Collaborative Group. Arima H, et al. Among authors: chalmers j. Stroke. 2005 Oct;36(10):2164-9. doi: 10.1161/01.STR.0000181115.59173.42. Epub 2005 Sep 1. Stroke. 2005. PMID: 16141420 Clinical Trial.
1,975 results